Rheumatoid arthritis and inflammatory conditions require consistent medication to control joint damage and pain. When Xeljanz costs force you to potentially ration doses, disease activity increases and disability progresses. Prescription expenses shouldn’t dictate whether you control inflammation.
This is why the team at The Rx Advocates assist by connecting people to Patient Assistance Programs (PAPs) that make JAK inhibitor treatment affordable. We handle applications so you can focus on disease management.
What is the Xeljanz Patient Assistance Program?
Drug manufacturers sponsor patient assistance programs for individuals facing financial constraints with biologic medications. The Xeljanz program offers continuous treatment access rather than short-term coupon relief.
We establish links between patients and these programs. Partnering with you and your rheumatologist, we assemble required documentation and submit thorough applications. We monitor progress until approval arrives. Once enrolled, we organize refills to maintain consistent medication supply. We work with over 100 companies whose programs include more than 800 FDA-approved medications.
Income limits improve chances but don’t guarantee enrollment since companies evaluate individually. We ensure submissions are detailed and complete.
How to Qualify
Eligibility depends on yearly household earnings and U.S. residency. We assess your finances against program standards to see if you satisfy requirements.
Criteria include:
- Individuals earning up to $40,000 annually
- Couples with combined income up to $60,000 annually
- Larger families with income up to $100,000 annually
- U.S. residency and valid prescription
Each patient’s situation is unique. Program guidelines vary. Reach out so we can evaluate your specific circumstances and see if you qualify.
Cost of Xeljanz
with The Rx Advocates
The monthly service fee depends on the number of medications you take. For example:
$80 / Month
$90 / Month
$100 / Month
$110 / Month
NOTE: In addition to our monthly service fee, we charge a one-time enrollment fee of $35.
Our service is month-to-month, so if you’re not happy with it, you may cancel at any time.
The Rx Advocates Can Help Reduce Xeljanz Costs
We’re not a coupon service, savings plan, or discount card. We navigate patient assistance programs.
Working with you and your healthcare providers, we prepare and submit required documents to pharmaceutical companies. We track application progress, securing approvals and managing refills.
You’ll pay a $35 enrollment fee, then monthly charges based on prescription count. No hidden fees. Prices stay consistent even if retail costs fluctuate.
Cost of Xeljanz vs Other Options
$80.00/month
$3118
* Source: GoodRx.com
Last Updated: September 29, 2025. Actual retail prices may vary by pharmacy and location.
Why PAPs Are Better Than Coupons
Coupons deliver immediate savings but include drawbacks for ongoing treatment. Patient assistance programs provide sustainable, long-term solutions.
Disadvantages of coupons
- Usage restrictions: Valid only at specific pharmacies or within timeframes
- Copay accumulators: May not contribute toward out-of-pocket maximums
- Time limits: Expire and become invalid
- Inadequate coverage: Medications remain expensive
Advantages of PAPs through The Rx Advocates
- Transparent pricing: Fixed monthly costs
- Lasting relief: More substantial savings than coupons
- Simplified process: We handle complex applications
- Dedicated support: Personalized assistance
Frequently Asked Questions (FAQ)
Those managing inflammatory conditions often ask these questions about Xeljanz expenses and eligibility.
With The Rx Advocates, patients pay a fixed monthly service fee, which depends on the number of medications covered.
- 1 Medication (Xeljanz only) – $80 per month
- 2 Medications (Xeljanz + 1 other) – $90 per month
- 3 Medications (Xeljanz + 2 others) – $100 per month
- 4+ Medications – $110 per month
Importantly, there are no hidden fees, and prices remain consistent even if retail costs fluctuate.
Cost depends on:
- Dosage: Prescribed strength
- Patient location: Geographic pricing differences
- Pharmacy location: Operational costs affect pricing
- Insurance: Coverage reduces costs
For cash-paying patients, out-of-pocket costs can be overwhelming.
Income guidelines: individuals up to $40,000, couples up to $60,000 combined, larger families up to $100,000 annually. Some manufacturers exclude state healthcare beneficiaries and government insurance holders. We believe everyone deserves access to affordable medications. Get in touch today so we can tailor services to your situation.
We streamline applications, ensuring efficient approval. Many patients abandon applications due to complexity. We simplify this by preparing documents, submitting to companies, and conducting follow-ups. Whether seeking savings on Xeljanz or multiple medications, we provide dedicated support.
About Xeljanz
Xeljanz (tofacitinib) is a Janus kinase inhibitor prescribed for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.
How it works: Inhibits Janus kinases in immune cell signaling, regulating inflammatory response. Differs from traditional disease-modifying drugs and biologics.
Available forms: Pill, extended-release tablets, oral solution. Dosages vary by condition.
Side effects:
- Common: upper respiratory infections, headache, diarrhea
- Serious: serious infections, blood cell changes, elevated liver enzymes, blood clots, lung cancer risk
Important: Tell your provider if you have a weak immune system, smoke, or have lung cancer history. Caution with immunosuppressive agents.
Get Started Today
Inflammatory conditions worsen when treatment gets interrupted. Skipping Xeljanz because of cost allows disease activity to escalate, causing joint damage and disability.
We connect individuals with patient assistance programs. If approved, access medication for a fixed monthly fee starting at $80.
Financial constraints shouldn’t prevent you from receiving healthcare. Contact us immediately to begin the enrollment process.
